Shattuck Labs (STTK) Non Operating Income (2019 - 2026)
Shattuck Labs (STTK) posted quarterly Non Operating Income of $778000.0 for Q1 2026, up 13.25% year-over-year from $687000.0 in Q1 2025, and up 13.25% quarter-over-quarter from $687000.0 in Q1 2025.
Powered by 
Analysis
Shattuck Labs (STTK) Non Operating Income (2019 - 2026) Analysis & Trends
Shattuck Labs (STTK) has reported Non Operating Income for 5 consecutive years, with $778000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Non Operating Income rose 13.25% year-over-year to $778000.0; the TTM figure through Mar 2026 stood at $236000.0 (down 36.56% YoY), while the FY2025 annual figure was $2.7 million, down 47.66% from the prior year.
- Non Operating Income advanced to $778000.0 in Q1 2026 per STTK's latest filing, from $687000.0 in the prior quarter.
- Across five years, Non Operating Income topped out at $778000.0 in Q1 2026 and bottomed at $687000.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.62 Bn | 131.77 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.73 Bn | 77.73 Bn | 3.93 Bn | 234.30 Mn |
| 3 | Argenx Se | 63.53 Bn | 58.35 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.23 Bn | 53.09 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - | -139.24 Mn |
| 6 | BeOne Medicines | 40.03 Bn | 34.93 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.50 Bn | 32.19 Bn | 992.69 Mn | -53.64 Mn |
| 8 | Royalty Pharma | 28.52 Bn | 27.68 Bn | - | -51.63 Mn |
| 9 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | - |
| 10 | Shattuck Labs | 879.90 Mn | 879.90 Mn | - | 1.00 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.00 Mn |
| Mar 31, 2026 | 778,000.00 |
| Jun 30, 2025 | 574,000.00 |
| Mar 31, 2025 | 687,000.00 |
| Dec 31, 2021 | -1.40 Mn |
| Sep 30, 2021 | 170,000.00 |
| Jun 30, 2021 | 914,000.00 |
| Mar 31, 2021 | 610,000.00 |
| Dec 31, 2020 | -1,000.00 |
| Sep 30, 2020 | 10,000.00 |
| Jun 30, 2020 | 112,000.00 |
| Mar 31, 2020 | 207,000.00 |
| Dec 31, 2019 | 255,000.00 |
| Sep 30, 2019 | 248,000.00 |